Does BEVACIZUMAB Cause Leukocytosis? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Leukocytosis have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.2% of all adverse event reports for BEVACIZUMAB.
122
Reports of Leukocytosis with BEVACIZUMAB
0.2%
of all BEVACIZUMAB reports
36
Deaths
81
Hospitalizations
How Dangerous Is Leukocytosis From BEVACIZUMAB?
Of the 122 reports, 36 (29.5%) resulted in death, 81 (66.4%) required hospitalization, and 6 (4.9%) were considered life-threatening.
Is Leukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which BEVACIZUMAB Alternatives Have Lower Leukocytosis Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ